Ecuadorian Catholic university conducting implementation science on cancer and diabetes equity in Latin American low-resource health systems.
PUCE is a research university in Quito, Ecuador that conducts implementation science — studying how evidence-based health interventions can actually be adopted in low-resource, real-world settings. Their work addresses health equity in Latin America: how cancer diagnosis programs and diabetes management can reach vulnerable and underserved populations who are typically excluded from mainstream healthcare. They bring irreplaceable on-the-ground presence in Ecuadorian and broader Latin American primary care networks, patient communities, and health system structures that European partners cannot access from within the EU. Their methodological contribution is the design and execution of quasi-experimental and mixed-methods studies that test whether interventions work in practice, not just in controlled conditions.
Both CEAD and EquityCancer-LA are explicitly implementation research projects — CEAD on diabetes and EquityCancer-LA on cancer diagnostics — focused on how interventions translate into real-world low-resource contexts.
EquityCancer-LA (2021-2026) directly targets equity in access to early cancer diagnosis across Latin American vulnerable populations, integrating primary care and IT tools.
CEAD (2019-2024) used a mixed-methods case study approach to contextualize evidence for Type 2 diabetes action in settings with limited health infrastructure.
EquityCancer-LA focuses specifically on integrated care pathways and primary care training to close the gap in cancer early detection across Latin America.
CEAD explicitly includes 'population engagement in knowledge generation' as a core element, reflecting a participatory research tradition.
Their first project, CEAD (2019), focused on Type 2 diabetes and established their identity as an implementation science partner — emphasis on methodology, knowledge generation with local populations, and understanding global health challenges in constrained settings. By 2021, their focus shifted to oncology and explicitly named Latin America as the geographic scope, reflecting a broader ambition: from a single disease to a regional health equity agenda spanning cancer control, integrated care, and primary care training. The direction is clear — they are building a cross-disease platform for testing and scaling health interventions across underserved Latin American populations.
PUCE is evolving from single-disease implementation studies toward a broader Latin American health equity research identity, making them an increasingly valuable partner for any consortium targeting real-world impact in low- and middle-income health systems.
PUCE has participated in both projects as a partner, never as a coordinator — a pattern consistent with their role as a field-access and regional expertise contributor rather than a project management hub. Their consortia are small and focused (8 unique partners across 2 projects), suggesting they are selected deliberately for specific geographic or methodological value. Working with PUCE likely means gaining access to Ecuadorian patient populations, primary care networks, and local regulatory knowledge in exchange for providing research infrastructure and EU funding channels.
PUCE has worked with 8 unique partners across 5 countries — a small but internationally diverse network that almost certainly spans European research institutions and other Latin American partners. Their limited partner count reflects highly targeted consortium membership rather than broad networking activity.
PUCE is one of very few Latin American universities active in H2020, giving them a rare combination of EU research standards and genuine institutional presence in the Ecuadorian and broader regional health landscape. For European researchers studying global health or low-resource settings, PUCE provides something that cannot be replicated from within Europe: real field access to Latin American patient communities, primary care systems, and the implementation challenges that make or break health interventions in practice. Any consortium designing health research that needs to demonstrate real-world relevance in Latin America would benefit directly from their presence.
